SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001321543-05-000004
Filing Date
2005-06-13
Accepted
2005-06-13 09:31:29
Documents
1
Period of Report
2005-06-09

Document Format Files

Seq Description Document Type Size
1 form4-cerrone_ex.html 4  
1 form4-cerrone_ex.xml 4 3395
  Complete submission text file 0001321543-05-000004.txt   5227
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Issuer) CIK: 0001142380 (see all company filings)

IRS No.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 PHAETON DRIVE MELVILLE NY 11747
Business Address
CERRONE GABRIEL (Reporting) CIK: 0001253803 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32325 | Film No.: 05891347